Cargando…

Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties

This study focusses on the fabrication of nano-carriers for delivery of ciprofloxacin through the nanoprecipitation process. This was done to examine the release of drug at the pH of stomach to find out the antibacterial action of ciprofloxacin loaded nanoparticles (NPs). Prepared NPs were character...

Descripción completa

Detalles Bibliográficos
Autores principales: Bukhari, Attaullah, Fatima, Zuha, Atta, Madiha, Nazir, Arif, Alshawwa, Samar Z., Alotaibi, Hadil F., Iqbal, Munawar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893093/
https://www.ncbi.nlm.nih.gov/pubmed/36743194
http://dx.doi.org/10.1177/15593258231152117
_version_ 1784881453399539712
author Bukhari, Attaullah
Fatima, Zuha
Atta, Madiha
Nazir, Arif
Alshawwa, Samar Z.
Alotaibi, Hadil F.
Iqbal, Munawar
author_facet Bukhari, Attaullah
Fatima, Zuha
Atta, Madiha
Nazir, Arif
Alshawwa, Samar Z.
Alotaibi, Hadil F.
Iqbal, Munawar
author_sort Bukhari, Attaullah
collection PubMed
description This study focusses on the fabrication of nano-carriers for delivery of ciprofloxacin through the nanoprecipitation process. This was done to examine the release of drug at the pH of stomach to find out the antibacterial action of ciprofloxacin loaded nanoparticles (NPs). Prepared NPs were characterized by Fourier Transform Infra-Red (FTIR) spectroscopy, Scanning Electron Microscopy (SEM), and particle size analyzer (PSA) techniques. Drug yield, loading, and sustained release was studied as function of time (up to 8 h). Antibacterial activity of ciprofloxacin loaded NPs were also determined against different gram-positive and gram-negative bacteria. Results revealed that nanoprecipitation is a suitable method for encapsulation of ciprofloxacin in poly(lactic-co-glycolic acid) PLGA NPs. The drug yield and drug loading were found to be 60%. The size range of NPs observed by PSA was in the range of 5.03–6.60 nm. It can be concluded that nanoformulation of ciprofloxacin loaded PLGA NPs can be used in stomach for longer period of time to enhance the bioavailability of the drug.
format Online
Article
Text
id pubmed-9893093
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-98930932023-02-03 Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties Bukhari, Attaullah Fatima, Zuha Atta, Madiha Nazir, Arif Alshawwa, Samar Z. Alotaibi, Hadil F. Iqbal, Munawar Dose Response Original Article This study focusses on the fabrication of nano-carriers for delivery of ciprofloxacin through the nanoprecipitation process. This was done to examine the release of drug at the pH of stomach to find out the antibacterial action of ciprofloxacin loaded nanoparticles (NPs). Prepared NPs were characterized by Fourier Transform Infra-Red (FTIR) spectroscopy, Scanning Electron Microscopy (SEM), and particle size analyzer (PSA) techniques. Drug yield, loading, and sustained release was studied as function of time (up to 8 h). Antibacterial activity of ciprofloxacin loaded NPs were also determined against different gram-positive and gram-negative bacteria. Results revealed that nanoprecipitation is a suitable method for encapsulation of ciprofloxacin in poly(lactic-co-glycolic acid) PLGA NPs. The drug yield and drug loading were found to be 60%. The size range of NPs observed by PSA was in the range of 5.03–6.60 nm. It can be concluded that nanoformulation of ciprofloxacin loaded PLGA NPs can be used in stomach for longer period of time to enhance the bioavailability of the drug. SAGE Publications 2023-01-30 /pmc/articles/PMC9893093/ /pubmed/36743194 http://dx.doi.org/10.1177/15593258231152117 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Article
Bukhari, Attaullah
Fatima, Zuha
Atta, Madiha
Nazir, Arif
Alshawwa, Samar Z.
Alotaibi, Hadil F.
Iqbal, Munawar
Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties
title Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties
title_full Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties
title_fullStr Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties
title_full_unstemmed Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties
title_short Poly Lactic-Co-Glycolic Acid Nano-Carriers for Encapsulation and Controlled Release of Hydrophobic Drug to Enhance the Bioavailability and Antimicrobial Properties
title_sort poly lactic-co-glycolic acid nano-carriers for encapsulation and controlled release of hydrophobic drug to enhance the bioavailability and antimicrobial properties
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893093/
https://www.ncbi.nlm.nih.gov/pubmed/36743194
http://dx.doi.org/10.1177/15593258231152117
work_keys_str_mv AT bukhariattaullah polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties
AT fatimazuha polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties
AT attamadiha polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties
AT nazirarif polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties
AT alshawwasamarz polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties
AT alotaibihadilf polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties
AT iqbalmunawar polylacticcoglycolicacidnanocarriersforencapsulationandcontrolledreleaseofhydrophobicdrugtoenhancethebioavailabilityandantimicrobialproperties